Effect of phenylepherine on spinal block for cesarean section.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- pregnant patients undergoing LSCSHealth Condition 2: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2015/10/006242
- Lead Sponsor
- niversity College of Medical Sciences and GTB Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
ASA physical status I or II and an uncomplicated singleton pregnancy of 37 weeks or greater gestation undergoing elective LSCS will be included.
Exclusion Criteria
Patients with extremes of height or weight (body mass index <20 kg/m2 or >35 kg/m2, height <145 cm or >180 cm),those who refuse consent, or with pregnancy induced hypertension, history of diabetes mellitus, cardiovascular or cerebrovascular diseases, fetal abnormalities or any contraindication to combined spinal epidural block will also be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The dose of intrathecal plain bupivacaineTimepoint: After Sub-arachnoid block, the spinal block both sensory and motor characteristics will be assessed at every 3 minutes for 15 minutes for adequacy of intrathecal dose
- Secondary Outcome Measures
Name Time Method mbilical artery pH and Apgar scoringTimepoint: Umbilical Artery pH at birth. <br/ ><br>Apgar scoring at birth and 5 minutes after birth